FRIDAY, Sept. 16, 2022 (HealthDay News) — In updated guidance issued Thursday, the World Health Organization now recommends against using the antibody drugs sotrovimab and casirivimab-imdevimab for patients with COVID-19. This recommendation replaces previous conditional recommendation for these antibody drugs. The change in guidance was based on emerging evidence thatContinue Reading

FRIDAY, Sept. 16, 2022 (HealthDay News) — For women with breast cancer, their race may help predict the success of hormone therapy given before surgery. In a new study, researchers found that Black women treated with hormone therapy before cancer surgery (so-called “neoadjuvant endocrine therapy”) may be more likely toContinue Reading

THURSDAY, Sept. 15, 2022 (HealthDay News) — Monkeypox cases continue to fall in the United States, but public health officials now are concerned that the virus is wending its way into communities of color. New case numbers are down by nearly half since early August, White House monkeypox response coordinatorContinue Reading

WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Chad Gradney underwent quadruple bypass open-heart surgery at age 27, and afterward spent eight fruitless years battling extremely high cholesterol levels. Then in 2012 he found himself back in an emergency room, again suffering from chest pain. “That’s when I found out threeContinue Reading

WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Cancer patients already have a lot to deal with emotionally and physically. But research shows that insured patients under 65 are also paying more for their treatments out-of-pocket than ever before. The study highlights the “growing financial burden for non-elderly patients with cancerContinue Reading